HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47012,
"recordsTotal": 47012,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=44400",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=43800",
"results": [
{
"registry_id": "NCT06850805",
"publication_url": "https://clinicaltrials.gov/study/NCT06850805",
"title": "A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Optinose US Inc.",
"sponsor_slug": "optinose-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959524",
"publication_url": "https://clinicaltrials.gov/study/NCT06959524",
"title": "AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114380",
"publication_url": "https://clinicaltrials.gov/study/NCT07114380",
"title": "Investigation of Cold Snare Polypectomy for Removing 10-20 mm 0-Ip Colorectal Polyp: One Feasibility and Safety Study",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Taiwan University Hospital",
"sponsor_slug": "national-taiwan-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023835",
"publication_url": "https://clinicaltrials.gov/study/NCT07023835",
"title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202884",
"publication_url": "https://clinicaltrials.gov/study/NCT07202884",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07181837",
"publication_url": "https://clinicaltrials.gov/study/NCT07181837",
"title": "A Multi-Center, Open-label, Phase 1/2 Trial of the Safety and Efficacy of MVX-220 Gene Therapy Administered by Intra-Cisterna Magna Injection to Participants With Angelman Syndrome",
"has_exemption": false,
"start_date": "2025-10-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MavriX Bio, LLC",
"sponsor_slug": "mavrix-bio-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708455",
"publication_url": "https://clinicaltrials.gov/study/NCT06708455",
"title": "Phase 2 Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Malignant Melanoma",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapa Therapeutics LLC",
"sponsor_slug": "rapa-therapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699121",
"publication_url": "https://clinicaltrials.gov/study/NCT06699121",
"title": "A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "LISCure Biosciences",
"sponsor_slug": "liscure-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842498",
"publication_url": "https://clinicaltrials.gov/study/NCT06842498",
"title": "A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "FibroGen",
"sponsor_slug": "fibrogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205601",
"publication_url": "https://clinicaltrials.gov/study/NCT07205601",
"title": "Phase 2a Assessment of Safety, Tolerability, and Efficacy of Repeated Dosing of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneration Biomedical, Inc.",
"sponsor_slug": "regeneration-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183319",
"publication_url": "https://clinicaltrials.gov/study/NCT07183319",
"title": "Circulating Tumor DNA Response Adapted Treatment De-escalation Metastatic Urothelial Carcinoma (CT-READ)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219602",
"publication_url": "https://clinicaltrials.gov/study/NCT07219602",
"title": "A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome (RUBENS Trial)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NewAmsterdam Pharma",
"sponsor_slug": "newamsterdam-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225712",
"publication_url": "https://clinicaltrials.gov/study/NCT07225712",
"title": "A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Tolerability, Safety, and Efficacy of Long-term Administration of SEP-363856 in Patients With Schizophrenia",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Co., Ltd.",
"sponsor_slug": "otsuka-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04901741",
"publication_url": "https://clinicaltrials.gov/study/NCT04901741",
"title": "An Open-label Phase 2 Study of Olaptesed Pegol (NOX-A12) Combined With Pembrolizumab and Nanoliposomal Irinotecan/5-FU/Leucovorin or Gemcitabine/Nab-paclitaxel in Microsatellite-stable Metastatic Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TME Pharma AG",
"sponsor_slug": "tme-pharma-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06067802",
"publication_url": "https://clinicaltrials.gov/study/NCT06067802",
"title": "A Phase II, Escalating Dose, Open Label Study to Evaluate the Safety of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jerry Vockley, MD, PhD",
"sponsor_slug": "jerry-vockley-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258407",
"publication_url": "https://clinicaltrials.gov/study/NCT07258407",
"title": "A Phase 1/2 Dose Escalation Trial With Administration Schedule Exploration Evaluating Single Agent TD001, a PSMA-Targeted Antibody-Drug Conjugate, in Patients With PSMA-Expressing Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "T.O.A.D. Oncology SA",
"sponsor_slug": "toad-oncology-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07249554",
"publication_url": "https://clinicaltrials.gov/study/NCT07249554",
"title": "Preliminary Safety and Efficacy of Semaglutide and Naltrexone Combination Therapy for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07263230",
"publication_url": "https://clinicaltrials.gov/study/NCT07263230",
"title": "An Open-label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Hidradenitis Suppurativa.",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05402384",
"publication_url": "https://clinicaltrials.gov/study/NCT05402384",
"title": "Evaluation of Efficacy and Safety of D-galactose Supplementation in SLC35A2-CDG, a Disorder of Hypogalactosylation",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva Morava-Kozicz",
"sponsor_slug": "eva-morava-kozicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03678025",
"publication_url": "https://clinicaltrials.gov/study/NCT03678025",
"title": "Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2018-09-24",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03947450",
"publication_url": "https://clinicaltrials.gov/study/NCT03947450",
"title": "Autologous Volar Fibroblast Injection Into the Stump Site of Amputees",
"has_exemption": false,
"start_date": "2019-09-05",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03984448",
"publication_url": "https://clinicaltrials.gov/study/NCT03984448",
"title": "Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas",
"has_exemption": false,
"start_date": "2019-10-22",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764642",
"publication_url": "https://clinicaltrials.gov/study/NCT05764642",
"title": "Renal Microvessel Imaging for Characterization of Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062875",
"publication_url": "https://clinicaltrials.gov/study/NCT06062875",
"title": "Effects of TNF Blockade on Human BPH/LUTS",
"has_exemption": false,
"start_date": "2024-01-24",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073665",
"publication_url": "https://clinicaltrials.gov/study/NCT06073665",
"title": "Levothyroxine Dosing in Older Individuals",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350045",
"publication_url": "https://clinicaltrials.gov/study/NCT06350045",
"title": "Renal Puncture Above the Eleventh Rib (High Supracostal Approach) Versus Subcostal Puncture in Percutaneous Nephrolithotomy for Treatment of Renal Stones in Adults: A Prospective Randomized Trial",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150417",
"publication_url": "https://clinicaltrials.gov/study/NCT06150417",
"title": "Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06853223",
"publication_url": "https://clinicaltrials.gov/study/NCT06853223",
"title": "A Randomized Trial of CCR5 Inhibition as a Complement to Lung Transplant Induction Immunosuppression",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150599",
"publication_url": "https://clinicaltrials.gov/study/NCT06150599",
"title": "Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212062",
"publication_url": "https://clinicaltrials.gov/study/NCT07212062",
"title": "A Phase II, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Sfatey and Tolerability of X/T+X-EC vs. Placebo in Participants With Alzheimer's Disease Currently Treated With Lecanemab.",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurology Office of South Florida",
"sponsor_slug": "neurology-office-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06822010",
"publication_url": "https://clinicaltrials.gov/study/NCT06822010",
"title": "A Phase II Trial of SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227857",
"publication_url": "https://clinicaltrials.gov/study/NCT07227857",
"title": "A Phase Ib/II First-in-human, Multicentre, Open-label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effect of Intrathecal S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Recherches Internationales Servier",
"sponsor_slug": "institut-de-recherches-internationales-servier",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699849",
"publication_url": "https://clinicaltrials.gov/study/NCT06699849",
"title": "A Phase 2/Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis",
"has_exemption": false,
"start_date": "2025-07-10",
"completion_date": "2028-04-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05719441",
"publication_url": "https://clinicaltrials.gov/study/NCT05719441",
"title": "A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06646276",
"publication_url": "https://clinicaltrials.gov/study/NCT06646276",
"title": "A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919965",
"publication_url": "https://clinicaltrials.gov/study/NCT06919965",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Investigator's Choice of Intravesical Chemotherapy in Participants With High-risk Non-muscle-invasive Bladder Cancer With Susceptible FGFR Alterations Who Had Received Intravesical Bacillus Calmette-Guérin (BCG)",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849298",
"publication_url": "https://clinicaltrials.gov/study/NCT05849298",
"title": "An International Prospective Open-label, Multi-center, Randomized, Non-comparative Phase II Study of Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) Alone and Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) in Combination With Androgen Receptor Pathway Inhibitors in Patients With PSMA PET Scan Positive Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-01-03",
"completion_date": "2028-04-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202247",
"publication_url": "https://clinicaltrials.gov/study/NCT07202247",
"title": "A Phase II Randomized Study of Interventions for Metabolic Protection Against Cardiometabolic Toxicity During Androgen Deprivation Therapy (IMPACT-ADT)",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2028-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784726",
"publication_url": "https://clinicaltrials.gov/study/NCT06784726",
"title": "Odronextamab for Relapsed/Refractory Large B-cell Lymphomas Before Definitive Lymphoma-Directed Therapies",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2028-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07231952",
"publication_url": "https://clinicaltrials.gov/study/NCT07231952",
"title": "A Phase II Study of Time-limited Combination of Pirtobrutinib, Venetoclax, and Rituximab in Treatment Naïve Patients With Waldenström's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) (PRoVen)",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2028-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156983",
"publication_url": "https://clinicaltrials.gov/study/NCT05156983",
"title": "A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial With Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of TAK-330 for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260683",
"publication_url": "https://clinicaltrials.gov/study/NCT06260683",
"title": "A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-Cigarettes on Smoking Behavior",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University Comprehensive Cancer Center",
"sponsor_slug": "ohio-state-university-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668181",
"publication_url": "https://clinicaltrials.gov/study/NCT06668181",
"title": "Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-Related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042438",
"publication_url": "https://clinicaltrials.gov/study/NCT07042438",
"title": "A Phase 2 Randomized Trial of Remodeling Intestinal Microbiota Using Fecal Microbiome Transplant (FMT) Among Recipients of Chimeric Antigen Receptor T Cells (CAR T)",
"has_exemption": false,
"start_date": "2026-01-17",
"completion_date": "2028-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023432",
"publication_url": "https://clinicaltrials.gov/study/NCT07023432",
"title": "Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04515836",
"publication_url": "https://clinicaltrials.gov/study/NCT04515836",
"title": "Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma",
"has_exemption": false,
"start_date": "2021-02-19",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04988386",
"publication_url": "https://clinicaltrials.gov/study/NCT04988386",
"title": "An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants With Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07156578",
"publication_url": "https://clinicaltrials.gov/study/NCT07156578",
"title": "A Long-Term, Open-Label Extension Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhythm Pharmaceuticals, Inc.",
"sponsor_slug": "rhythm-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05859568",
"publication_url": "https://clinicaltrials.gov/study/NCT05859568",
"title": "Baseline Performance and Fitting Parameters for Sonova Products",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Advanced Bionics",
"sponsor_slug": "advanced-bionics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973187",
"publication_url": "https://clinicaltrials.gov/study/NCT06973187",
"title": "A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07130903",
"publication_url": "https://clinicaltrials.gov/study/NCT07130903",
"title": "A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Barbara Ann Karmanos Cancer Institute",
"sponsor_slug": "barbara-ann-karmanos-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06129864",
"publication_url": "https://clinicaltrials.gov/study/NCT06129864",
"title": "A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)",
"has_exemption": false,
"start_date": "2023-12-14",
"completion_date": "2028-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01869114",
"publication_url": "https://clinicaltrials.gov/study/NCT01869114",
"title": "A Phase II Study of Azacitidine and Sirolimus for the Treatment of High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Refractory to or Not Eligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2013-07-08",
"completion_date": "2028-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Cancer Center at Thomas Jefferson University",
"sponsor_slug": "sidney-kimmel-cancer-center-at-thomas-jefferson-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06907615",
"publication_url": "https://clinicaltrials.gov/study/NCT06907615",
"title": "An Open-label, Multi-center, Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-04-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Henlius Biotech",
"sponsor_slug": "shanghai-henlius-biotech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05984277",
"publication_url": "https://clinicaltrials.gov/study/NCT05984277",
"title": "A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357533",
"publication_url": "https://clinicaltrials.gov/study/NCT06357533",
"title": "A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)",
"has_exemption": false,
"start_date": "2024-04-11",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788938",
"publication_url": "https://clinicaltrials.gov/study/NCT06788938",
"title": "Tarlatamab in Advanced DLL3-Expressing Tumors Including Neuroendocrine Neoplasms",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06911502",
"publication_url": "https://clinicaltrials.gov/study/NCT06911502",
"title": "A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05536349",
"publication_url": "https://clinicaltrials.gov/study/NCT05536349",
"title": "Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2028-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05939414",
"publication_url": "https://clinicaltrials.gov/study/NCT05939414",
"title": "An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease Recurrence in Adult Male Patients With Prostate-specific Membrane Antigen (PSMA) Positive Oligometastatic Prostate Cancer (OMPC)",
"has_exemption": false,
"start_date": "2024-03-12",
"completion_date": "2028-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109219",
"publication_url": "https://clinicaltrials.gov/study/NCT07109219",
"title": "A Modular Phase I/II, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AZD4512 Monotherapy or in Combination With Anticancer Agent(s) in Participants With Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218770",
"publication_url": "https://clinicaltrials.gov/study/NCT07218770",
"title": "A Phase 1/2a Study of REGN7041 (Anti-CD3 Monoclonal Antibody) in Participants With Active Noninfectious Uveitis Affecting the Posterior Segment",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06071767",
"publication_url": "https://clinicaltrials.gov/study/NCT06071767",
"title": "A Phase I/IIa Randomized, Placebo-Controlled Trial of Conserved-Mosaic T-cell Vaccine in a Regimen With Vesatolimod and Broadly Neutralizing Antibodies in Adults Initiated on Suppressive Antiretroviral Therapy During Acute HIV-1",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358872",
"publication_url": "https://clinicaltrials.gov/study/NCT06358872",
"title": "Azithromycine Pour la Vie Des Enfants au Niger II",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01760005",
"publication_url": "https://clinicaltrials.gov/study/NCT01760005",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2012-12-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02718001",
"publication_url": "https://clinicaltrials.gov/study/NCT02718001",
"title": "Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)",
"has_exemption": false,
"start_date": "2015-02-06",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04089059",
"publication_url": "https://clinicaltrials.gov/study/NCT04089059",
"title": "A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)",
"has_exemption": false,
"start_date": "2020-01-10",
"completion_date": "2028-04-30",
"has_results": true,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04862286",
"publication_url": "https://clinicaltrials.gov/study/NCT04862286",
"title": "OptIMMize-2: A Phase 3 Multicenter, Single-arm, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Risankizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Completed Participation in Study M19-977 (OptIMMize-1)",
"has_exemption": false,
"start_date": "2021-07-24",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05164172",
"publication_url": "https://clinicaltrials.gov/study/NCT05164172",
"title": "Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine",
"has_exemption": false,
"start_date": "2021-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269394",
"publication_url": "https://clinicaltrials.gov/study/NCT05269394",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-12-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05243797",
"publication_url": "https://clinicaltrials.gov/study/NCT05243797",
"title": "Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4",
"has_exemption": false,
"start_date": "2022-09-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting European Myeloma Network",
"sponsor_slug": "stichting-european-myeloma-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04922333",
"publication_url": "https://clinicaltrials.gov/study/NCT04922333",
"title": "Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery",
"has_exemption": false,
"start_date": "2023-03-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05681299",
"publication_url": "https://clinicaltrials.gov/study/NCT05681299",
"title": "Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05840211",
"publication_url": "https://clinicaltrials.gov/study/NCT05840211",
"title": "A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) (HER2 IHC0 or HER2-low [IHC 1+, IHC 2+/ISH-]) Inoperable, Locally Advanced, or Metastatic Breast Cancer and Have Received Endocrine Therapy",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05313243",
"publication_url": "https://clinicaltrials.gov/study/NCT05313243",
"title": "Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05540574",
"publication_url": "https://clinicaltrials.gov/study/NCT05540574",
"title": "Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06020716",
"publication_url": "https://clinicaltrials.gov/study/NCT06020716",
"title": "A Phase 4 Double Blinded Study With Two Different Interventions, Each With Two Arms, to Evaluate the Clinical Efficacy of Antibiotics and the Role of Microbiology, Immunology and Genetics in Children Aged 9-36 Months With Chronic Wet Cough.",
"has_exemption": false,
"start_date": "2023-08-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Helse Stavanger HF",
"sponsor_slug": "helse-stavanger-hf",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007183",
"publication_url": "https://clinicaltrials.gov/study/NCT06007183",
"title": "A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (PXVX0317) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen",
"has_exemption": false,
"start_date": "2023-08-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092034",
"publication_url": "https://clinicaltrials.gov/study/NCT06092034",
"title": "Gene Therapy for Danon Disease: A Phase 2 Study Evaluating the Efficacy and Safety of Intravenously Administered Adeno-Associated Virus Serotype 9 (rAAV9) Vector Containing the Human LAMP2 Isoform B Transgene (RP-A501; AAV9.LAMP2B) in Male Patients With Danon Disease",
"has_exemption": false,
"start_date": "2023-09-05",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rocket Pharmaceuticals Inc.",
"sponsor_slug": "rocket-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05980000",
"publication_url": "https://clinicaltrials.gov/study/NCT05980000",
"title": "Open-Label, Randomized Phase 2 Trial of Ramucirumab in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-Line Treatment of PD-L1 Positive, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC)",
"has_exemption": false,
"start_date": "2023-10-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06162611",
"publication_url": "https://clinicaltrials.gov/study/NCT06162611",
"title": "Generating Evidence to Improve Same-day Etonogestrel (ENG) Implant Insertion for Emergency Contraception",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lori Gawron",
"sponsor_slug": "lori-gawron",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05383742",
"publication_url": "https://clinicaltrials.gov/study/NCT05383742",
"title": "A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109467",
"publication_url": "https://clinicaltrials.gov/study/NCT06109467",
"title": "A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05822362",
"publication_url": "https://clinicaltrials.gov/study/NCT05822362",
"title": "Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06346067",
"publication_url": "https://clinicaltrials.gov/study/NCT06346067",
"title": "A Randomized, Open-label Phase III Study in Patients With Previously Treated Unresectable or Metastatic NRAS Mutant Cutaneous Melanoma Comparing the Combination of Naporafenib + Trametinib to Physician's Choice of Therapy (Dacarbazine, Temozolomide or Trametinib Monotherapy) With a Dose Optimization lead-in [SEACRAFT-2]",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Erasca, Inc.",
"sponsor_slug": "erasca-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05992831",
"publication_url": "https://clinicaltrials.gov/study/NCT05992831",
"title": "Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06411210",
"publication_url": "https://clinicaltrials.gov/study/NCT06411210",
"title": "Obesity Complicating Type 1 Diabetes in Young Adults: Physiology and Impact of GLP-1 Analogue Anti-obesity Treatment on Cardiometabolic Risk Factors",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06547216",
"publication_url": "https://clinicaltrials.gov/study/NCT06547216",
"title": "A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)",
"has_exemption": false,
"start_date": "2024-07-25",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194851",
"publication_url": "https://clinicaltrials.gov/study/NCT06194851",
"title": "A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06724237",
"publication_url": "https://clinicaltrials.gov/study/NCT06724237",
"title": "A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients With Peripheral T Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eastern Cooperative Oncology Group",
"sponsor_slug": "eastern-cooperative-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712420",
"publication_url": "https://clinicaltrials.gov/study/NCT06712420",
"title": "Neoadjuvant Chemotherapy Versus Upfront Surgery for Locally Advanced Resectable Gall Bladder Cancer : A Randomized Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajiv Gandhi Cancer Institute & Research Center, India",
"sponsor_slug": "rajiv-gandhi-cancer-institute-research-center-india",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722755",
"publication_url": "https://clinicaltrials.gov/study/NCT06722755",
"title": "Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788990",
"publication_url": "https://clinicaltrials.gov/study/NCT06788990",
"title": "A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bicara Therapeutics",
"sponsor_slug": "bicara-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06767514",
"publication_url": "https://clinicaltrials.gov/study/NCT06767514",
"title": "A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06859268",
"publication_url": "https://clinicaltrials.gov/study/NCT06859268",
"title": "A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals With Obesity",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858254",
"publication_url": "https://clinicaltrials.gov/study/NCT06858254",
"title": "Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apeiron Research Center",
"sponsor_slug": "apeiron-research-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866275",
"publication_url": "https://clinicaltrials.gov/study/NCT06866275",
"title": "Suramin for the Treatment of Autism Trial (STAT): A Randomized, Double Blind, Crossover Trial of KZ101 in a Male Pediatric Population With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Orange County",
"sponsor_slug": "childrens-hospital-of-orange-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06929286",
"publication_url": "https://clinicaltrials.gov/study/NCT06929286",
"title": "COMparative Prospective Assessment Through Clinically Integrated Randomized Trials Evaluating Intravesical Treatments: The COMPARE IT Trial",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931821",
"publication_url": "https://clinicaltrials.gov/study/NCT06931821",
"title": "Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899711",
"publication_url": "https://clinicaltrials.gov/study/NCT06899711",
"title": "A Prospective Study to Evaluate the Protective Effects of External Cranial Prosthesis on Incidence of Sunken Flap Syndrome in Decompressive Craniectomy Patients",
"has_exemption": false,
"start_date": "2025-04-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06636136",
"publication_url": "https://clinicaltrials.gov/study/NCT06636136",
"title": "Transtibial Osseointegration Surgery Study (TOSS)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Walter Reed National Military Medical Center",
"sponsor_slug": "walter-reed-national-military-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957704",
"publication_url": "https://clinicaltrials.gov/study/NCT06957704",
"title": "Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Federal University of São Paulo",
"sponsor_slug": "federal-university-of-sao-paulo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852365",
"publication_url": "https://clinicaltrials.gov/study/NCT06852365",
"title": "Resistant Starch Usage in Polycystic Ovary Syndrome: Impact on Cardiometabolic Dysfunction and the Gut Microbiome (CORS-PCOS)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06405607",
"publication_url": "https://clinicaltrials.gov/study/NCT06405607",
"title": "Psilocybin vs Ketamine for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937086",
"publication_url": "https://clinicaltrials.gov/study/NCT06937086",
"title": "A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228078",
"publication_url": "https://clinicaltrials.gov/study/NCT07228078",
"title": "An Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Alzheimer's Disease (Study SNK01-AD02)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NKGen Biotech, Inc.",
"sponsor_slug": "nkgen-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06981078",
"publication_url": "https://clinicaltrials.gov/study/NCT06981078",
"title": "A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess Efficacy and Safety of Verekitug (UPB-101) in Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Upstream Bio Inc.",
"sponsor_slug": "upstream-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06556693",
"publication_url": "https://clinicaltrials.gov/study/NCT06556693",
"title": "Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy",
"has_exemption": false,
"start_date": "2025-08-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zoll Medical Corporation",
"sponsor_slug": "zoll-medical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06982521",
"publication_url": "https://clinicaltrials.gov/study/NCT06982521",
"title": "A Phase 3 Open-Label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment With a CDK4/6 Inhibitor",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Relay Therapeutics, Inc.",
"sponsor_slug": "relay-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011719",
"publication_url": "https://clinicaltrials.gov/study/NCT07011719",
"title": "A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153471",
"publication_url": "https://clinicaltrials.gov/study/NCT07153471",
"title": "A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06835400",
"publication_url": "https://clinicaltrials.gov/study/NCT06835400",
"title": "An Open-Label, Randomized, Two-stage Study to Determine Dose Optimization, Safety, and Noninferiority of Oral Paclitaxel + Encequidar Compared to IV Paclitaxel in Subjects With HER2 Negative Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Health Hope Pharma",
"sponsor_slug": "health-hope-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06848140",
"publication_url": "https://clinicaltrials.gov/study/NCT06848140",
"title": "Using High Definition Transcranial Direct Current Stimulation to Treat Verbal Retrieval Deficits Secondary to Chronic Traumatic Brain Injury (STIM-CTBI)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858787",
"publication_url": "https://clinicaltrials.gov/study/NCT06858787",
"title": "The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219966",
"publication_url": "https://clinicaltrials.gov/study/NCT07219966",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219953",
"publication_url": "https://clinicaltrials.gov/study/NCT07219953",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Alcohol Use Disorder (RENEW-ALC-2)",
"has_exemption": false,
"start_date": "2025-10-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219173",
"publication_url": "https://clinicaltrials.gov/study/NCT07219173",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213804",
"publication_url": "https://clinicaltrials.gov/study/NCT07213804",
"title": "FRAmework-01: A Two-Part Phase 3 Study of LY4170156 Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and LY4170156 Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734039",
"publication_url": "https://clinicaltrials.gov/study/NCT06734039",
"title": "Impact of Anatomy-Based Frequency (ABF) Allocations on Early Performance Outcomes in MED-EL Cochlear Implant Recipients",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Med-El Corporation",
"sponsor_slug": "med-el-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089576",
"publication_url": "https://clinicaltrials.gov/study/NCT07089576",
"title": "A Prospective, Multi-center Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA in the Open Repair of Aortic Arch Aneurysms and Dissections",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Artivion Inc.",
"sponsor_slug": "artivion-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07236606",
"publication_url": "https://clinicaltrials.gov/study/NCT07236606",
"title": "A Phase 3, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RGX 121 in Pediatric Participants With Neuronopathic MPS II (Hunter Syndrome)",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regenxbio Inc.",
"sponsor_slug": "regenxbio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07234968",
"publication_url": "https://clinicaltrials.gov/study/NCT07234968",
"title": "Randomized Controlled Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07244705",
"publication_url": "https://clinicaltrials.gov/study/NCT07244705",
"title": "An Open-label, Multicenter, Phase 1/2 Study Exploring the Safety and Efficacy of ABT-301 in Combination With Tislelizumab and Bevacizumab in Participants With Proficient Mismatch Repair (pMMR)/Non-Microsatellite Instability-High (Non-MSI-H) Locally Advanced or Metastatic Colorectal Cancer (mCRC)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Anbogen Therapeutics, Inc.",
"sponsor_slug": "anbogen-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06320951",
"publication_url": "https://clinicaltrials.gov/study/NCT06320951",
"title": "Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07125235",
"publication_url": "https://clinicaltrials.gov/study/NCT07125235",
"title": "Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) mHealth Randomized Controlled Hybrid Type I Effectiveness Implementation Trial",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06258525",
"publication_url": "https://clinicaltrials.gov/study/NCT06258525",
"title": "A Phase II, Open-Label Trial of S-Adenosylmethionine (SAMe) in Prevention of Oxaliplatin Associated Liver Injury",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224022",
"publication_url": "https://clinicaltrials.gov/study/NCT07224022",
"title": "NACho: A Phase II Study of Neo-Adjuvant Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "John Strickler, M.D.",
"sponsor_slug": "john-strickler-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226453",
"publication_url": "https://clinicaltrials.gov/study/NCT07226453",
"title": "A Target Validation and Efficacy Study of Metformin in Patients With Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03567824",
"publication_url": "https://clinicaltrials.gov/study/NCT03567824",
"title": "A Phase 2 Open Label Study of Magnesium L-Lactate Dihydrate (MLD10) 10 mEq Extended-Release Caplets Administered BID for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus Followed by a Blinded Random Off Phase",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmalyte Solutions LLC",
"sponsor_slug": "pharmalyte-solutions-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06615752",
"publication_url": "https://clinicaltrials.gov/study/NCT06615752",
"title": "A Phase I/II Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin With Docetaxel in Castration-resistant Prostate Cancer Patients",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Charles Drew University of Medicine and Science",
"sponsor_slug": "charles-drew-university-of-medicine-and-science",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04860635",
"publication_url": "https://clinicaltrials.gov/study/NCT04860635",
"title": "An Open Label Safety Study of a Single Administration of F14 in Patients Undergoing Unilateral Total Knee Replacement",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arthritis Innovation Corporation",
"sponsor_slug": "arthritis-innovation-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04214262",
"publication_url": "https://clinicaltrials.gov/study/NCT04214262",
"title": "A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC",
"has_exemption": false,
"start_date": "2020-08-13",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04906408",
"publication_url": "https://clinicaltrials.gov/study/NCT04906408",
"title": "The Effects of Post-Operative Interventions on Surgical Site Occurrences in Abdominal Wall Reconstructions: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-09-17",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764395",
"publication_url": "https://clinicaltrials.gov/study/NCT05764395",
"title": "A Phase II Study to Evaluate the Safety and Efficacy of Rigosertib (ON 01910) Plus Pembrolizumab in Patients With Metastatic Melanoma Refractory to Immune Checkpoint Blockade",
"has_exemption": false,
"start_date": "2023-05-09",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899153",
"publication_url": "https://clinicaltrials.gov/study/NCT05899153",
"title": "Quantifying Patient-specific Changes in Neuromuscular Control in Cerebral Palsy: Adaptation and Biofeedback During Gait",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029309",
"publication_url": "https://clinicaltrials.gov/study/NCT06029309",
"title": "A Phase 1/2 Study of Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Alvaro Alencar, MD",
"sponsor_slug": "alvaro-alencar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706284",
"publication_url": "https://clinicaltrials.gov/study/NCT06706284",
"title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Marzieh Salehi",
"sponsor_slug": "marzieh-salehi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831058",
"publication_url": "https://clinicaltrials.gov/study/NCT06831058",
"title": "A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499285",
"publication_url": "https://clinicaltrials.gov/study/NCT06499285",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants With Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) (RENEW)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06930651",
"publication_url": "https://clinicaltrials.gov/study/NCT06930651",
"title": "A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07172841",
"publication_url": "https://clinicaltrials.gov/study/NCT07172841",
"title": "Randomized Controlled Study on Non-invasive Diagnostics of Shunt Obstruction in Adult Hydrocephalus",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Göteborg University",
"sponsor_slug": "goteborg-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209371",
"publication_url": "https://clinicaltrials.gov/study/NCT07209371",
"title": "Rifaximin Versus No Intervention in Patients With IgA Monoclonal Gammopathy of Undetermined Significance",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193317",
"publication_url": "https://clinicaltrials.gov/study/NCT06193317",
"title": "Effects of taVNS on Fibromyalgia Pain",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03701282",
"publication_url": "https://clinicaltrials.gov/study/NCT03701282",
"title": "A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)",
"has_exemption": false,
"start_date": "2019-02-12",
"completion_date": "2028-05-07",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05892068",
"publication_url": "https://clinicaltrials.gov/study/NCT05892068",
"title": "Window of Opportunity Analysis of Pre-Operative Tucatinib for Surgically Resected HER2+ Brain Metastases: Understanding Mechanisms of Resistance",
"has_exemption": false,
"start_date": "2023-05-09",
"completion_date": "2028-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07184996",
"publication_url": "https://clinicaltrials.gov/study/NCT07184996",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis.",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2028-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05874635",
"publication_url": "https://clinicaltrials.gov/study/NCT05874635",
"title": "Use of Signos mHealth Platform in Participants With Non-Insulin Dependent Type 2 Diabetes: Weight and Blood Glucose",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Signos Inc",
"sponsor_slug": "signos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136650",
"publication_url": "https://clinicaltrials.gov/study/NCT06136650",
"title": "MK-5684-004: A Phase 3, Randomized, Open-label Study of Opevesostat Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA) (OMAHA-004)",
"has_exemption": false,
"start_date": "2023-12-18",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06414863",
"publication_url": "https://clinicaltrials.gov/study/NCT06414863",
"title": "Treatment Effects of Invisalign Palatal Expander System and Hyrax Palatal Expander - A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-05-10",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04064060",
"publication_url": "https://clinicaltrials.gov/study/NCT04064060",
"title": "A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials",
"has_exemption": false,
"start_date": "2019-08-12",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984523",
"publication_url": "https://clinicaltrials.gov/study/NCT06984523",
"title": "A Phase II Single-Arm Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142252",
"publication_url": "https://clinicaltrials.gov/study/NCT07142252",
"title": "Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2028-05-13",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210086",
"publication_url": "https://clinicaltrials.gov/study/NCT07210086",
"title": "Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2028-05-13",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650359",
"publication_url": "https://clinicaltrials.gov/study/NCT05650359",
"title": "A Randomized and Controlled Study of the Use of Orthopulse Photobiomodulation for Acceleration of Orthodontic Tooth Movement With Fixed Appliances",
"has_exemption": false,
"start_date": "2022-10-13",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Biolux Technology GmbH",
"sponsor_slug": "biolux-technology-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846671",
"publication_url": "https://clinicaltrials.gov/study/NCT06846671",
"title": "A Phase 3, Open-Label, Randomized Study of BGB-16673 Compared to Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituximab Retreatment) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both BTK and BCL2 Inhibitors",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954987",
"publication_url": "https://clinicaltrials.gov/study/NCT06954987",
"title": "A Two Cohort, Randomized, Double-Blind, Placebo-Controlled, Phase II Multi-Center Signal-Finding Study of Venetoclax Combined With Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation Then Venetoclax Maintenance in Adult Patients With Acute Myeloid Leukemia in First Complete Remission: A MyeloMATCH Sub-Study",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608291",
"publication_url": "https://clinicaltrials.gov/study/NCT05608291",
"title": "A Phase 3 Trial of Fianlimab (Anti-LAG-3) and Cemiplimab Versus Pembrolizumab in the Adjuvant Setting in Patients With Completely Resected High-risk Melanoma",
"has_exemption": false,
"start_date": "2023-01-16",
"completion_date": "2028-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015983",
"publication_url": "https://clinicaltrials.gov/study/NCT07015983",
"title": "A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Active SLE (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2028-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463587",
"publication_url": "https://clinicaltrials.gov/study/NCT06463587",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",
"sponsor_slug": "merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220785",
"publication_url": "https://clinicaltrials.gov/study/NCT07220785",
"title": "A Two-Part, Randomized, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Mibavademab in Patients With Generalized Lipodystrophy",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044726",
"publication_url": "https://clinicaltrials.gov/study/NCT07044726",
"title": "Betadine vs Sterile Water for Periurethral Preparation Prior to Straight Catherization in the Clinic Setting: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2028-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05884333",
"publication_url": "https://clinicaltrials.gov/study/NCT05884333",
"title": "Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults",
"has_exemption": false,
"start_date": "2023-05-22",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260163",
"publication_url": "https://clinicaltrials.gov/study/NCT06260163",
"title": "A Phase 3 Randomized, Open-label Induction, Double-blind Maintenance, Parallel-group, Multicenter Protocol to Evaluate the Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424288",
"publication_url": "https://clinicaltrials.gov/study/NCT06424288",
"title": "EASi-HF Preserved - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) ≥40%",
"has_exemption": false,
"start_date": "2024-06-17",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03581136",
"publication_url": "https://clinicaltrials.gov/study/NCT03581136",
"title": "Phase II Multi-center Trial Evaluating 5 Fraction S-PBI (Stereotactic Partial Breast Irradiation) for Early Stage Breast Cancer Using the GammaPod",
"has_exemption": false,
"start_date": "2019-04-22",
"completion_date": "2028-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06685068",
"publication_url": "https://clinicaltrials.gov/study/NCT06685068",
"title": "A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-13",
"completion_date": "2028-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06012695",
"publication_url": "https://clinicaltrials.gov/study/NCT06012695",
"title": "A Phase Ib/II, Open-label Study of NBM-BMX As Monotherapy or in Combination with Radiotherapy and Temozolomide in Subjects with Solid Tumors or Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novelwise Pharmaceutical Corporation",
"sponsor_slug": "novelwise-pharmaceutical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986993",
"publication_url": "https://clinicaltrials.gov/study/NCT06986993",
"title": "Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866562",
"publication_url": "https://clinicaltrials.gov/study/NCT05866562",
"title": "Dupilumab in the Treatment of Pediatric Alopecia Areata",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06266611",
"publication_url": "https://clinicaltrials.gov/study/NCT06266611",
"title": "Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679946",
"publication_url": "https://clinicaltrials.gov/study/NCT06679946",
"title": "An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06949228",
"publication_url": "https://clinicaltrials.gov/study/NCT06949228",
"title": "Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ProMedica Health System",
"sponsor_slug": "promedica-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07164443",
"publication_url": "https://clinicaltrials.gov/study/NCT07164443",
"title": "A Phase 3 Randomized, Double-blind, Placebo-controlled Study of Pasritamig (JNJ-78278343), a T Cell Redirecting Agent Targeting Human Kallikrein 2, + Best Supportive Care Versus Best Supportive Care for Metastatic Castration-resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918977",
"publication_url": "https://clinicaltrials.gov/study/NCT06918977",
"title": "Evaluation of a Novel Telemedicine Clinic for Patients With DM2 on Multiple Daily Insulin (MDI) Regimens",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224711",
"publication_url": "https://clinicaltrials.gov/study/NCT07224711",
"title": "The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Abdominal Surgery (IMPALA ERAS)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03047746",
"publication_url": "https://clinicaltrials.gov/study/NCT03047746",
"title": "Unrelated And Partially Matched Related Donor Peripheral Blood Stem Cell Transplantation (PSCT) With TCR αβ + T Cell And B Cell Depletion For Patients With Acquired And Inherited Bone Marrow Failure",
"has_exemption": false,
"start_date": "2017-02-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03422302",
"publication_url": "https://clinicaltrials.gov/study/NCT03422302",
"title": "Measuring the Effectiveness of a Continuous Positive Airway Pressure (CPAP) Device to Reduce Tumor Motion and Increase Lung Volume Expansion in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Tumors That Move With Respiration",
"has_exemption": false,
"start_date": "2018-03-16",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03417297",
"publication_url": "https://clinicaltrials.gov/study/NCT03417297",
"title": "A Pilot Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy",
"has_exemption": false,
"start_date": "2018-04-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04471974",
"publication_url": "https://clinicaltrials.gov/study/NCT04471974",
"title": "A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-01-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411654",
"publication_url": "https://clinicaltrials.gov/study/NCT04411654",
"title": "An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose LY3884961 in Infants With Type 2 Gaucher Disease",
"has_exemption": false,
"start_date": "2021-06-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03742414",
"publication_url": "https://clinicaltrials.gov/study/NCT03742414",
"title": "SEAL (Stopping Eczema and ALlergy) Study: Prevent the Allergic March by Enhancing the Skin Barrier",
"has_exemption": false,
"start_date": "2021-06-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kari Nadeau, MD, PhD",
"sponsor_slug": "kari-nadeau-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05083481",
"publication_url": "https://clinicaltrials.gov/study/NCT05083481",
"title": "A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination With Pembrolizumab and/or Standard Therapies Including Chemotherapy and/or Immunotherapy in Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2021-10-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05045950",
"publication_url": "https://clinicaltrials.gov/study/NCT05045950",
"title": "Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06284473",
"publication_url": "https://clinicaltrials.gov/study/NCT06284473",
"title": "Intranasal Ketamine as a Supplement to Local Anesthesia to Reduce Pain Associated With Minor Procedures in the Emergency Department",
"has_exemption": false,
"start_date": "2022-05-25",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Loyola University",
"sponsor_slug": "loyola-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05047172",
"publication_url": "https://clinicaltrials.gov/study/NCT05047172",
"title": "Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508789",
"publication_url": "https://clinicaltrials.gov/study/NCT05508789",
"title": "Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease",
"has_exemption": false,
"start_date": "2022-10-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05528133",
"publication_url": "https://clinicaltrials.gov/study/NCT05528133",
"title": "Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05896293",
"publication_url": "https://clinicaltrials.gov/study/NCT05896293",
"title": "Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders",
"has_exemption": false,
"start_date": "2023-02-03",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephanie B. Seminara, MD",
"sponsor_slug": "stephanie-b-seminara-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05737199",
"publication_url": "https://clinicaltrials.gov/study/NCT05737199",
"title": "A Single-arm Open-label Phase II Trial to Assess the Efficacy and Safety of Pembrolizumab for Unresectable Advanced or Recurrent Ovarian Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Niigata University Medical & Dental Hospital",
"sponsor_slug": "niigata-university-medical-dental-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866536",
"publication_url": "https://clinicaltrials.gov/study/NCT05866536",
"title": "Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years",
"has_exemption": false,
"start_date": "2023-05-04",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05943210",
"publication_url": "https://clinicaltrials.gov/study/NCT05943210",
"title": "The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.",
"has_exemption": false,
"start_date": "2023-05-22",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04796792",
"publication_url": "https://clinicaltrials.gov/study/NCT04796792",
"title": "Ultrasound Technology to Fragment and Reposition Urinary Stones",
"has_exemption": false,
"start_date": "2023-07-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05805839",
"publication_url": "https://clinicaltrials.gov/study/NCT05805839",
"title": "Advanced MR and PET Imaging in Inflammatory Demyelinating Diseases of the Central Nervous System",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023589",
"publication_url": "https://clinicaltrials.gov/study/NCT06023589",
"title": "A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)",
"has_exemption": false,
"start_date": "2023-08-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05948943",
"publication_url": "https://clinicaltrials.gov/study/NCT05948943",
"title": "A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.",
"has_exemption": false,
"start_date": "2023-11-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003348",
"publication_url": "https://clinicaltrials.gov/study/NCT06003348",
"title": "Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305039",
"publication_url": "https://clinicaltrials.gov/study/NCT06305039",
"title": "Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments - Part 2",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, College Park",
"sponsor_slug": "university-of-maryland-college-park",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06094192",
"publication_url": "https://clinicaltrials.gov/study/NCT06094192",
"title": "Personalized Synchronization of Cortical Rhythms to Improve Memory in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2023-12-20",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston University Charles River Campus",
"sponsor_slug": "boston-university-charles-river-campus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06391775",
"publication_url": "https://clinicaltrials.gov/study/NCT06391775",
"title": "First-In-Human, Open-Label, Dose Escalation Trial With Expansion Cohorts to Evaluate the Safety and Preliminary Efficacy of GEN1055 as Monotherapy and as Combination Therapy in Subjects With Malignant Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347978",
"publication_url": "https://clinicaltrials.gov/study/NCT06347978",
"title": "A Double-Blinded, Randomized, Crossover Trial of Stereoencephalography- Guided Four-Lead Personalized Deep Brain Stimulation for Treatment-Refractory Obsessive Compulsive Disorder (SEEG-Guided DBS for OCD)",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Moses Lee, MD, PhD",
"sponsor_slug": "andrew-moses-lee-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264882",
"publication_url": "https://clinicaltrials.gov/study/NCT06264882",
"title": "Cardiometabolic Consequences of the Loss of Ovarian Function",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205836",
"publication_url": "https://clinicaltrials.gov/study/NCT06205836",
"title": "Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-06-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05932199",
"publication_url": "https://clinicaltrials.gov/study/NCT05932199",
"title": "Combination of Induction Durvalumab and Tremelimumab Alone Versus Durvalumab and Tremelimumab With Chemotherapy for Potentially Resectable Pleural Mesothelioma",
"has_exemption": false,
"start_date": "2024-07-03",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05662462",
"publication_url": "https://clinicaltrials.gov/study/NCT05662462",
"title": "ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961487",
"publication_url": "https://clinicaltrials.gov/study/NCT06961487",
"title": "Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy (OUTER LIMITS)",
"has_exemption": false,
"start_date": "2024-07-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475742",
"publication_url": "https://clinicaltrials.gov/study/NCT06475742",
"title": "A Phase 3, Multicenter, Open-label, Single-arm, Extension Study to Evaluate the Long-term Safety and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy",
"has_exemption": false,
"start_date": "2024-07-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viatris Innovation GmbH",
"sponsor_slug": "viatris-innovation-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06031688",
"publication_url": "https://clinicaltrials.gov/study/NCT06031688",
"title": "A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)",
"has_exemption": false,
"start_date": "2024-08-08",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06320366",
"publication_url": "https://clinicaltrials.gov/study/NCT06320366",
"title": "Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06334315",
"publication_url": "https://clinicaltrials.gov/study/NCT06334315",
"title": "Influence of Genetics Variants on the Pharmacokinetics and Pharmacodynamics of Combined Oral Contraceptive Pill Users",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06481592",
"publication_url": "https://clinicaltrials.gov/study/NCT06481592",
"title": "A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Endometrial Cancer.",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06116682",
"publication_url": "https://clinicaltrials.gov/study/NCT06116682",
"title": "A Phase II Study of Amivantamab SC (Subcutaneous) in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06617325",
"publication_url": "https://clinicaltrials.gov/study/NCT06617325",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06674577",
"publication_url": "https://clinicaltrials.gov/study/NCT06674577",
"title": "A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vera Therapeutics, Inc.",
"sponsor_slug": "vera-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06630234",
"publication_url": "https://clinicaltrials.gov/study/NCT06630234",
"title": "A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06533748",
"publication_url": "https://clinicaltrials.gov/study/NCT06533748",
"title": "SJALL23H: Combination Antigen-Directed Induction Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06857942",
"publication_url": "https://clinicaltrials.gov/study/NCT06857942",
"title": "A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight in Clinical Practice",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06827236",
"publication_url": "https://clinicaltrials.gov/study/NCT06827236",
"title": "A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer",
"has_exemption": false,
"start_date": "2025-04-23",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976853",
"publication_url": "https://clinicaltrials.gov/study/NCT06976853",
"title": "Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984861",
"publication_url": "https://clinicaltrials.gov/study/NCT06984861",
"title": "Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Advanced Stage Human Papilloma Virus Associated Oropharyngeal Carcinoma",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986083",
"publication_url": "https://clinicaltrials.gov/study/NCT06986083",
"title": "A Randomized Controlled Trial of Modifications to Prostate Needle-Based Procedures",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925152",
"publication_url": "https://clinicaltrials.gov/study/NCT06925152",
"title": "COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Tennessee",
"sponsor_slug": "university-of-tennessee",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06821542",
"publication_url": "https://clinicaltrials.gov/study/NCT06821542",
"title": "A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038200",
"publication_url": "https://clinicaltrials.gov/study/NCT07038200",
"title": "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937099",
"publication_url": "https://clinicaltrials.gov/study/NCT06937099",
"title": "A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06911632",
"publication_url": "https://clinicaltrials.gov/study/NCT06911632",
"title": "MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tempus AI",
"sponsor_slug": "tempus-ai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06853184",
"publication_url": "https://clinicaltrials.gov/study/NCT06853184",
"title": "Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amivas Inc.",
"sponsor_slug": "amivas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133308",
"publication_url": "https://clinicaltrials.gov/study/NCT07133308",
"title": "A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients With Severe Alopecia Areata With an Open-label Extension Period",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Pharmaceutical Industries, Inc.",
"sponsor_slug": "sun-pharmaceutical-industries-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070232",
"publication_url": "https://clinicaltrials.gov/study/NCT07070232",
"title": "A Phase I/II, Open-label, Adaptive Two-part Trial to Evaluate the Safety, Efficacy, Optimal Dose and Pharmacokinetics of BNT326 as Monotherapy and in Combination With Cancer Immunotherapies in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-12",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020312",
"publication_url": "https://clinicaltrials.gov/study/NCT07020312",
"title": "Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery: A Blinded Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07086976",
"publication_url": "https://clinicaltrials.gov/study/NCT07086976",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07131787",
"publication_url": "https://clinicaltrials.gov/study/NCT07131787",
"title": "Optimizing Rehabilitation After Achilles Tendon Rupture Repair: The Role of Blood Flow Restriction Training in Tendon and Muscle Recovery",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06624475",
"publication_url": "https://clinicaltrials.gov/study/NCT06624475",
"title": "Randomized Phase II Trial Neoadjuvant Opdualag Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053059",
"publication_url": "https://clinicaltrials.gov/study/NCT07053059",
"title": "Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07198451",
"publication_url": "https://clinicaltrials.gov/study/NCT07198451",
"title": "Efficacy Evaluation of Submucosal Injection of Gemcitabine in Preventing Recurrence of Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized, Single-Blind, Multicenter Clinical Study",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai University of Traditional Chinese Medicine",
"sponsor_slug": "shanghai-university-of-traditional-chinese-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07110233",
"publication_url": "https://clinicaltrials.gov/study/NCT07110233",
"title": "Prospective Phase 2 Trial of Yttrium-90 Radiation Segmentectomy for Unresectable Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076212",
"publication_url": "https://clinicaltrials.gov/study/NCT07076212",
"title": "Phase II Study Evaluating NALIRIFOX Versus Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228832",
"publication_url": "https://clinicaltrials.gov/study/NCT07228832",
"title": "A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06738407",
"publication_url": "https://clinicaltrials.gov/study/NCT06738407",
"title": "Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Among Adolescent and Young Adult Females in the United States",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Westat",
"sponsor_slug": "westat",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904378",
"publication_url": "https://clinicaltrials.gov/study/NCT06904378",
"title": "Phase I/II Clinical Trial of Ontegimod and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma: Reprogramming Tumor-associated Myeloid Cells",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979492",
"publication_url": "https://clinicaltrials.gov/study/NCT06979492",
"title": "Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247162",
"publication_url": "https://clinicaltrials.gov/study/NCT07247162",
"title": "A Double-blind, Randomised, 30-week Placebo-controlled Phase IV Study to Assess the Efficacy and Safety of Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RECORDATI GROUP",
"sponsor_slug": "recordati-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00882895",
"publication_url": "https://clinicaltrials.gov/study/NCT00882895",
"title": "Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2009-05-05",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01950351",
"publication_url": "https://clinicaltrials.gov/study/NCT01950351",
"title": "Phase II Trial of Hypofractionated Proton Beam Therapy in Men With Localized Prostate Adenocarcinoma",
"has_exemption": false,
"start_date": "2013-10-10",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03080974",
"publication_url": "https://clinicaltrials.gov/study/NCT03080974",
"title": "Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2017-08-14",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05381103",
"publication_url": "https://clinicaltrials.gov/study/NCT05381103",
"title": "PSMA-PET to Guide Prostatectomy: A Randomized Trial",
"has_exemption": false,
"start_date": "2021-10-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Five Eleven Pharma, Inc.",
"sponsor_slug": "five-eleven-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04883671",
"publication_url": "https://clinicaltrials.gov/study/NCT04883671",
"title": "Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial",
"has_exemption": false,
"start_date": "2021-12-27",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05928936",
"publication_url": "https://clinicaltrials.gov/study/NCT05928936",
"title": "Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD",
"has_exemption": false,
"start_date": "2022-11-11",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027879",
"publication_url": "https://clinicaltrials.gov/study/NCT06027879",
"title": "Anti-viral T-cell Therapy by Gamma Capture for High-risk Patients With Acquired or Inherited Immune Defects",
"has_exemption": false,
"start_date": "2024-01-08",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul Szabolcs",
"sponsor_slug": "paul-szabolcs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150560",
"publication_url": "https://clinicaltrials.gov/study/NCT06150560",
"title": "A Phase III, Randomized, Double-Blind, Placebo Controlled Clinical Trial Evaluating the Benefits and Mechanism Of Action Of Angiotensin-II Receptor Blocker On Cardiovascular Remodeling In Patients With Repaired Coarctation Of Aorta",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06610305",
"publication_url": "https://clinicaltrials.gov/study/NCT06610305",
"title": "Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression: A Crossover Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-09-02",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06070350",
"publication_url": "https://clinicaltrials.gov/study/NCT06070350",
"title": "Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Philip Spinella",
"sponsor_slug": "philip-spinella",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731478",
"publication_url": "https://clinicaltrials.gov/study/NCT06731478",
"title": "A Multicenter, Randomized, Open-Label, Phase 3 Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab Versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab as First-Line Treatment in Participants With Unresectable, Locally Advanced or Metastatic HER2-Positive Gastric Or Gastroesophageal Junction (GEJ) Cancer (Destiny-Gastric05)",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644781",
"publication_url": "https://clinicaltrials.gov/study/NCT06644781",
"title": "A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06397274",
"publication_url": "https://clinicaltrials.gov/study/NCT06397274",
"title": "A Phase II, Randomized, Double-Blind, Placebo-controlled, Single-Center Study to Evaluate the Safety and Efficacy of Stemchymal (Allogeneic Adipose-derived Mesenchymal Stem Cells) Infusion for the Treatment of PolyQ Spinocerebellar Ataxia",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Steminent US, Inc.",
"sponsor_slug": "steminent-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07014917",
"publication_url": "https://clinicaltrials.gov/study/NCT07014917",
"title": "Randomized Phase II Study of Intermittent Versus Continuous Venetoclax Therapy With Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zulfa Omer",
"sponsor_slug": "zulfa-omer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071402",
"publication_url": "https://clinicaltrials.gov/study/NCT07071402",
"title": "A Single-center, Single-arm, Open Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Xijing Hospital",
"sponsor_slug": "xijing-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058012",
"publication_url": "https://clinicaltrials.gov/study/NCT07058012",
"title": "A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab and Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NSABP Foundation Inc",
"sponsor_slug": "nsabp-foundation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06503146",
"publication_url": "https://clinicaltrials.gov/study/NCT06503146",
"title": "18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06448286",
"publication_url": "https://clinicaltrials.gov/study/NCT06448286",
"title": "PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218926",
"publication_url": "https://clinicaltrials.gov/study/NCT07218926",
"title": "A Phase 3, Randomized, Multicenter, Open-Label Study of IDRX-42 (GSK6042981) Versus Sunitinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3)",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07198724",
"publication_url": "https://clinicaltrials.gov/study/NCT07198724",
"title": "ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarah Sammons, MD",
"sponsor_slug": "sarah-sammons-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747236",
"publication_url": "https://clinicaltrials.gov/study/NCT04747236",
"title": "A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)",
"has_exemption": false,
"start_date": "2021-02-19",
"completion_date": "2028-06-02",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05481827",
"publication_url": "https://clinicaltrials.gov/study/NCT05481827",
"title": "ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study",
"has_exemption": false,
"start_date": "2022-07-12",
"completion_date": "2028-06-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Gyroscope Therapeutics Limited",
"sponsor_slug": "gyroscope-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06840392",
"publication_url": "https://clinicaltrials.gov/study/NCT06840392",
"title": "A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult Patients With Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-06-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453876",
"publication_url": "https://clinicaltrials.gov/study/NCT06453876",
"title": "Percutaneous Embolectomy, Ultrasund Assisted Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-06-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Jesper Kjaergaard",
"sponsor_slug": "jesper-kjaergaard",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824168",
"publication_url": "https://clinicaltrials.gov/study/NCT06824168",
"title": "A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia in Complete Remission",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-06-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07088068",
"publication_url": "https://clinicaltrials.gov/study/NCT07088068",
"title": "A Randomized, Double-blind, 2-arm, Phase 3 Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Newly Diagnosed Stage 3 Type 1 Diabetes (T1D)",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-06-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169578",
"publication_url": "https://clinicaltrials.gov/study/NCT07169578",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2028-06-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07170150",
"publication_url": "https://clinicaltrials.gov/study/NCT07170150",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-06-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902272",
"publication_url": "https://clinicaltrials.gov/study/NCT06902272",
"title": "A Phase 2 Study of Circulating Tumor DNA to Predict Response to Neoadjuvant Treatment and De-escalation Adjuvant Immunotherapy in Early-Stage NSCLC (DNA-PREDICT)",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2028-06-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06467357",
"publication_url": "https://clinicaltrials.gov/study/NCT06467357",
"title": "DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig Versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer",
"has_exemption": false,
"start_date": "2024-08-12",
"completion_date": "2028-06-12",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06624059",
"publication_url": "https://clinicaltrials.gov/study/NCT06624059",
"title": "A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients With Resectable Stage I-III Non-Small Cell Lung Cancer, Selected According to Biomarker Status",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2028-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007637",
"publication_url": "https://clinicaltrials.gov/study/NCT07007637",
"title": "A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "MoonLake Immunotherapeutics AG",
"sponsor_slug": "moonlake-immunotherapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06929273",
"publication_url": "https://clinicaltrials.gov/study/NCT06929273",
"title": "A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04930653",
"publication_url": "https://clinicaltrials.gov/study/NCT04930653",
"title": "A Phase II Study of Combination Extracorporeal Photopheresis (ECP) and Mogamulizumab in Erythrodermic CTCL",
"has_exemption": false,
"start_date": "2022-10-19",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05327686",
"publication_url": "https://clinicaltrials.gov/study/NCT05327686",
"title": "Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)",
"has_exemption": false,
"start_date": "2023-02-01",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616793",
"publication_url": "https://clinicaltrials.gov/study/NCT05616793",
"title": "An Open Label, Dose Exploration, Safety and Tolerability Study of a Subretinal Injection of an OPGx-001 Gene Vector to Participants With LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)",
"has_exemption": false,
"start_date": "2023-06-15",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Opus Genetics, Inc",
"sponsor_slug": "opus-genetics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05096481",
"publication_url": "https://clinicaltrials.gov/study/NCT05096481",
"title": "Phase 2 Trial of a Novel Peptide Vaccine (PEP-CMV) Targeting CMV Antigen for Newly Diagnosed Pediatric High-grade Glioma and Diffuse Intrinsic Pontine Glioma and Recurrent Medulloblastoma",
"has_exemption": false,
"start_date": "2024-07-18",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06459180",
"publication_url": "https://clinicaltrials.gov/study/NCT06459180",
"title": "A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (TroFuse-020/GOG-3101/ENGOT-cx20)",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06506279",
"publication_url": "https://clinicaltrials.gov/study/NCT06506279",
"title": "Motor Recovery Through Plasticity-Inducing Cortical Stimulation",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06290609",
"publication_url": "https://clinicaltrials.gov/study/NCT06290609",
"title": "Control of Incomplete Spinal Cord Injury-Related Spasticity by Means of Vibrotactile Coordinated Reset Fingertip Stimulation",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2028-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02621021",
"publication_url": "https://clinicaltrials.gov/study/NCT02621021",
"title": "A Phase II Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab",
"has_exemption": false,
"start_date": "2015-12-04",
"completion_date": "2028-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05904080",
"publication_url": "https://clinicaltrials.gov/study/NCT05904080",
"title": "Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05562830",
"publication_url": "https://clinicaltrials.gov/study/NCT05562830",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants With PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma (KEYMAKER-U04): Substudy 04A",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2028-06-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747351",
"publication_url": "https://clinicaltrials.gov/study/NCT06747351",
"title": "A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04464226",
"publication_url": "https://clinicaltrials.gov/study/NCT04464226",
"title": "An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies",
"has_exemption": false,
"start_date": "2020-10-20",
"completion_date": "2028-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04603807",
"publication_url": "https://clinicaltrials.gov/study/NCT04603807",
"title": "Randomized, Open Label, Multicenter, Phase III Study of Entrectinib Versus Crizotinib in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer Harboring ROS1 Gene Rearrangements With and Without Central Nervous System Metastases",
"has_exemption": false,
"start_date": "2021-09-30",
"completion_date": "2028-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06180278",
"publication_url": "https://clinicaltrials.gov/study/NCT06180278",
"title": "A Long-term, Open-label, Low-interventional Safety Study of Inebilizumab in the Treatment of NMOSD (N-MOmentum LT)",
"has_exemption": false,
"start_date": "2024-04-02",
"completion_date": "2028-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925737",
"publication_url": "https://clinicaltrials.gov/study/NCT06925737",
"title": "A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2028-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107945",
"publication_url": "https://clinicaltrials.gov/study/NCT07107945",
"title": "A Randomised, Double-blind, Placebo-controlled Trial With an Open-label Extension to Assess the Pharmacokinetics, Safety, and Efficacy of Empagliflozin Tablets in Paediatric Patients With Chronic Kidney Disease (EMPA-KIDNEY® Kids)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780670",
"publication_url": "https://clinicaltrials.gov/study/NCT06780670",
"title": "PSMAcTION: A Phase II/III, Open-label, International, Multicenter, Randomized Study of AAA817 Versus Standard of Care in the Treatment of Adult Participants With PSMA Positive Metastatic Castration-resistant Prostate Cancer Who Progressed on or After [177Lu]Lu-PSMA Targeted Therapy",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-06-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06319820",
"publication_url": "https://clinicaltrials.gov/study/NCT06319820",
"title": "A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations",
"has_exemption": false,
"start_date": "2024-04-18",
"completion_date": "2028-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190196",
"publication_url": "https://clinicaltrials.gov/study/NCT07190196",
"title": "A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2028-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224360",
"publication_url": "https://clinicaltrials.gov/study/NCT07224360",
"title": "Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01000350",
"publication_url": "https://clinicaltrials.gov/study/NCT01000350",
"title": "Intravenous Saline on Exercise Tolerance in Orthostatic Intolerance",
"has_exemption": false,
"start_date": "2009-10-31",
"completion_date": "2028-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02016248",
"publication_url": "https://clinicaltrials.gov/study/NCT02016248",
"title": "Prospective Evaluation of CyberKnife Stereotactic Body Radiotherapy for Localized Prostate Cancer: Risk Stratified Monotherapy Versus Boost",
"has_exemption": false,
"start_date": "2012-06-30",
"completion_date": "2028-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MemorialCare Health System",
"sponsor_slug": "memorialcare-health-system",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02064673",
"publication_url": "https://clinicaltrials.gov/study/NCT02064673",
"title": "Randomized Trial of Adjuvant Curcumin After Prostatectomy",
"has_exemption": false,
"start_date": "2014-05-31",
"completion_date": "2028-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yair Lotan",
"sponsor_slug": "yair-lotan",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01818661",
"publication_url": "https://clinicaltrials.gov/study/NCT01818661",
"title": "Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech",
"has_exemption": false,
"start_date": "2018-07-01",
"completion_date": "2028-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03708224",
"publication_url": "https://clinicaltrials.gov/study/NCT03708224",
"title": "A Phase II Study of Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck",
"has_exemption": false,
"start_date": "2019-03-08",
"completion_date": "2028-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alain Algazi",
"sponsor_slug": "alain-algazi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03933631",
"publication_url": "https://clinicaltrials.gov/study/NCT03933631",
"title": "A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery",
"has_exemption": false,
"start_date": "2019-05-01",
"completion_date": "2028-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}